Tests to Immediately Assess Efficacy of BioLargo Technologies to Inactivate SarS-COV-2 (COVID-19)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/2012/31/21

Funding

  • BioLargo, Inc: $24,960.00